-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: September 2011
Research!America Report: Investment in Health Research Remains Stagnant
By Research!America The U.S. public and private sectors invested $140.5 billion in 2010 on research to find new ways to treat, cure and prevent disease and disability, according to Research!America’s latest annual estimate. Health research spending accounted for only 5.5% of the $2.6 trillion the U.S. spent on health care in 2010. Health research as a percentage of health care spending has hovered around 5.5% since 2005, remaining essentially stagnant. Investment in health research experienced Read More >
BIO Investor Forum Company Snapshot: GlobeImmune, Inc.
The BIO Investor Forum will be here before we know it, and we wanted to take the opportunity to highlight some of the companies who will be presenting at the 10th anniversary event. In our first Company Snapshot, hear from Timothy C. Rodell, the President and Chief Executive Officer of GlobeImmune, Inc. Company Snapshot Q: What are the short-term and long-term priorities for your company? Short term – in oncology, completing the GI-4000 phase Read More >
Q&A on Emmy Award Winning Biotech Education Campaign
While the biotechnology industry was born in Northern California over thirty years ago, companies falling under its broad umbrella can now be found in every corner of the world. From humble beginnings, its impact can now be seen in everything from consumer goods to cancer drugs. None-the-less, Northern California remains the center of the industry’s growing orbit. Many of the world’s greatest research institutions and biotech companies were born here and remain headquartered here. To Read More >
Virginia BIO Hosts Free Live Streaming Panel for Start-Ups
It’s a bit late notice, but if you’re going to be at your desk during lunch today, you should check out the following panel discussion entitled “Entrepreneurship Failures and Successes: The Perspective of Entrepreneurial Faculty.” The Virginia Biotechnology Association (VABIO) is pleased offer an opportunity to view the sold out Greater Richmond Bioscience Luncheon live on the web through our new LiveStream channel. The program will take place Thursday, September 8, from 12:00-1:30 p.m., and program Read More >
“Contagion” Portrays Our Vulnerability to a Global Pandemic
Earlier this month, the movie Contagion opened in theaters. With a star-studded cast including Matt Damon, Kate Winslet, and Gwyneth Paltrow, this action-thriller about the spread of a deadly virus is sure to attract a large audience. While Hollywood has been known to alter or exaggerate the facts to enhance the storyline, it is reported that Steven Soderbergh and his team aimed to realistically portray a pandemic. As Matt Damon stated in an IMDb interview, Read More >
